| Calculating cost per event avoided using a composite number needed to treat Joshua C. Toliver et al. | 2026 | 1 citations |
| Modeling the cost-effectiveness of the next-generation COVID-19 mRNA-1283 vaccine in the United States K Fust et al. | 2026 | 1 citations |
| Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison Srinivas Teppala et al. | 2026 | 0 citations |
| Changes in drug price reduction trends during Japan’s transition to an annualized revision environment: a comparative analysis using open data from the national claims database Koichi Tsuda et al. | 2026 | 0 citations |
| Cost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare Joshua A. Roth et al. | 2026 | 0 citations |
| The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study Lucía Silva-Fernández et al. | 2026 | 0 citations |
| Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors Jesse D. Ortendahl et al. | 2026 | 0 citations |
| Global burden of disease due to young-onset dementia and the forecast for 2050: update from global burden of disease study 2021 Yoonseo Park et al. | 2026 | 0 citations |
| Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United States Alon Yehoshua et al. | 2026 | 0 citations |
| Epidemiology and economic burden of medically attended influenza and influenza-like illness in Germany, 2016–2019 Anna C. Meyer et al. | 2026 | 0 citations |
| Trends in industry-sponsored clinical trial activity since passage of the Inflation Reduction Act Genia Long | 2026 | 0 citations |
| Model-based evaluation of colorectal cancer screening effectiveness: three rounds of multitarget stool DNA testing versus one colonoscopy Michael Dore et al. | 2026 | 0 citations |
| Estimating the public health and economic impact of increased COVID-19 annual vaccination coverage in the 60 years and older population in Spain Santiago Moreno Guillén et al. | 2026 | 0 citations |
| Cost-effectiveness of treatment and care of patients with gastrointestinal inflammatory diseases: a systematic review Kristina Randlová et al. | 2026 | 0 citations |
| Cost-effectiveness of pembrolizumab plus chemotherapy vs cemiplimab plus chemotherapy for first-line metastatic non–small cell lung cancer: a US payer perspective using a matching-adjusted indirect comparison Danmeng Huang et al. | 2026 | 0 citations |
| Loss of productivity among commercially insured patients with pulmonary arterial hypertension in the United States A. Watzker et al. | 2026 | 0 citations |
| Real-world healthcare resource utilization and clinical outcomes among patients with relapsed/refractory multiple myeloma receiving ciltacabtagene autoleucel after four or more prior lines of therapy in inpatient versus outpatient settings Murali Janakiram et al. | 2026 | 0 citations |
| The full value of mRNA seasonal influenza and endemic-stage COVID-19 combination vaccines: a taxonomy J. P. Sevilla et al. | 2026 | 0 citations |
| Cost per event avoided: adopt or avoid? Panagiotis Petrou et al. | 2026 | 0 citations |
| Safeguarding Quality in Health and Medical Science Information Today Scott C. Ratzan et al. | 2026 | 0 citations |